There are currently 6 active clinical trials seeking participants for Critical Limb Ischemia research studies. The states with the highest number of trials for Critical Limb Ischemia participants are Florida, California, Texas and Ohio.
Nutrition in Patient With Critical Limb Ischemia
Recruiting
A prospective pilot study examining nutritional supplements among vascular surgery patients with Critical Limb Ischemia (CLI). CLI patients have a high rate of malnutrition and has the potential to benefit greatly from nutritional intervention. The investigators plan to evaluate nutrition and functional status of patients by assessing objective lab values and the use of the hand grip strength test. Providing perioperative nutritional supplements to patients has potentially improved their nutriti... Read More
Gender:
ALL
Ages:
Between 18 years and 99 years
Trial Updated:
12/01/2024
Locations: Boston Medical Center, Boston, Massachusetts
Conditions: Critical Limb Ischemia, Malnutrition, Nutritional Supplements
Trial to Assess Chelation Therapy in Critical Limb Ischemia
Recruiting
TACT3a is a double blind, placebo-controlled, randomized trial to test a novel therapy, edetate disodium-based chelation of environmentally acquired toxic metals, to reduce cardiovascular events including amputation in high-risk diabetic patients.
Gender:
ALL
Ages:
50 years and above
Trial Updated:
08/20/2024
Locations: Mount Sinai Medical Center, Miami Beach, Florida
Conditions: Critical Limb Ischemia, Diabetes
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
Recruiting
A prospective, single-arm, multi-center study designed to gather additional information on the LimFlow System.
Gender:
All
Ages:
Between 18 years and 95 years
Trial Updated:
05/31/2024
Locations: University of California, San Diego Health, La Jolla, California +29 locations
Conditions: Critical Limb Ischemia, Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia
MOTIV BTK Randomized Controlled Trial
Recruiting
Pre-market clinical evaluation of the MOTIV Sirolimus-Eluting Bioresorbable Scaffold for the planned treatment of infrapopliteal lesions.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/26/2024
Locations: Adventist Health, Saint Helena, California +3 locations
Conditions: Critical Limb Ischemia
CRUSH PAD: Real-world Outcomes Following Use of the Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions
Recruiting
The primary goal of the study is to obtain effect size data on the use of Shockwave Intravascular Lithotripsy (IVL) technology in calcified common femoral lesions in patients with peripheral artery disease for a series of endpoints, including target lesion revascularization and health status, to enable future planning of comparative effectiveness research.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/25/2024
Locations: Yale New Haven Health, New Haven, Connecticut
Conditions: Femoral Arterial Calcification, Peripheral Arterial Disease, Claudication, Critical Limb Ischemia
Serranator Recoil Study
Recruiting
The study objective is to assess the ability to define and measure post treatment recoil in infrapopliteal arteries. Preliminary evidence as to the differences between serration angioplasty and standard balloon angioplasty as defined by post treatment recoil, lumen gain, and dissection will be collected.
Gender:
All
Ages:
18 years and above
Trial Updated:
06/07/2022
Locations: Stanford University, Palo Alto, California +1 locations
Conditions: Peripheral Arterial Disease, Critical Limb Ischemia